BRCA1 and BRCA2 gene pathogenic variants account for most hereditary breast cancer
and are increasingly used to determine eligibility for PARP inhibitor (PARPi) therapy of …

As research laboratories and clinics collaborate to achieve precision medicine, both
communities are required to understand mandated electronic health/medical record …

Answer questions and earn CME/CNE Each year, the American Cancer Society (ACS)
publishes a summary of its guidelines for early cancer detection along with a report on data …

Women at high risk of developing breast cancer are a heterogeneous group of women
including those with and without high-risk germline mutation/s. Prevention in these women …

Screening for breast cancer with mammography has been shown to decrease mortality from
breast cancer, and mammography is the mainstay of screening for clinically occult disease …

Answer questions and earn CME/CNE Each year the American Cancer Society (ACS)
publishes a summary of its guidelines for early cancer detection, data and trends in cancer …

The standard initial management of epithelial ovarian cancer consists of surgical staging,
operative tumour debulking including total abdominal hysterectomy and bilateral salpingo …

Breast cancer is the most common cancer affecting women worldwide. Prediction models
stratify a woman's risk for developing cancer and can guide screening recommendations …

Background: Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are
associated with increased risks for breast, ovarian, and other types of cancer. Purpose: To …

Purpose We investigated the respective contribution (in terms of cancer yield and stage at
diagnosis) of clinical breast examination (CBE), mammography, ultrasound, and quality …